| Date | Time | Source | Headline | Symbol | Company |
| 04/30/2014 | 4:36PM | Edgar (US Regulatory) | Amended Annual Report (10-k/a) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 04/23/2014 | 4:27PM | Edgar (US Regulatory) | Annual Statement of Changes in Beneficial Ownership (5) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 04/16/2014 | 7:35AM | Business Wire | ARIAD to Webcast Conference Call on First Quarter 2014 Financial Results | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 04/11/2014 | 8:00AM | PR Newswire (US) | Clinical Trial Results and Initiation, Endowment, Product Launches, and Appointments - Analyst Notes on Regeneron, Questcor, ... | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 04/09/2014 | 10:05AM | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 04/03/2014 | 4:32PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 04/03/2014 | 4:31PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 04/03/2014 | 4:31PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 04/03/2014 | 4:30PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 04/03/2014 | 4:29PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 04/03/2014 | 4:29PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 04/03/2014 | 4:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 04/02/2014 | 8:00AM | PR Newswire (US) | Clinical Study Initiations, Stock Price Updates, and Strategic Agreements - Analyst Notes on Ariad, Jazz, Intercept, Communit... | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 04/02/2014 | 7:35AM | Business Wire | ARIAD Announces Appointment of Hugh Cole, Senior Pharmaceutical-Industry Executive, as Chief Business Officer | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 03/31/2014 | 12:52PM | PR Newswire (US) | Technical Pointers on Top Gainers -- Research on ARIAD Pharma, Arotech, Restoration Hardware Holdings, and Sprouts Farmers Ma... | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 03/25/2014 | 9:22AM | Business Wire | ARIAD startet Phase-2-Zulassungsstudie ALTA für AP26113 an Patienten mit nicht-kleinzelligem Lungenkrebs | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 03/25/2014 | 9:21AM | Business Wire | ARIAD annonce le démarrage de l’essai pivot de Phase 2 « ALTA » portant sur l’AP26113 administré à des patients at... | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 03/24/2014 | 7:35AM | Business Wire | ARIAD Announces Initiation of Pivotal Phase 2 ALTA Trial of AP26113 in Patients with Non-Small Cell Lung Cancer | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 03/21/2014 | 5:31PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 03/21/2014 | 5:29PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 03/21/2014 | 5:28PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 03/21/2014 | 5:22PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 03/21/2014 | 5:21PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 03/21/2014 | 4:12PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 03/21/2014 | 4:11PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 03/21/2014 | 4:10PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 03/12/2014 | 8:00AM | PR Newswire (US) | Financial Results, Clinical Study Updates, Clinical Trial Results, Business Spin-Offs, and New Joint Ventures - Analyst Notes... | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 03/11/2014 | 10:12AM | PR Newswire (US) | Most Active Equities Technical Snapshot: SandRidge Energy, Ariad Pharma, Groupon, and Vodafone | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 03/05/2014 | 7:24AM | PR Newswire (US) | New Appointments, Contract Extensions, Share Price Movements, Conference Schedules, and Closing of Public Offerings - Analyst... | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 03/03/2014 | 5:13PM | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |